NCT06522997: An ongoing trial by Bayer
This trial is ongoing. It must report results 10 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06522997 |
|---|---|
| Title | A Phase 2b Dose-finding, Randomized, Placebo-controlled, Double-blind Study to Evaluate Efficacy and Safety of BAY 3283142 on Top of Standard of Care in Reducing Albuminuria in Patients With Chronic Kidney Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 8, 2024 |
| Completion date | Feb. 12, 2026 |
| Required reporting date | Feb. 12, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |